Closer Weekly on MSN
Barry Manilow Reveals Doctors Worried He Might Not Survive ICU Scare After Lung Cancer Surgery
Barry Manilow recently gave more details about his lung cancer surgery that was supposed to be a “no brainer” but actually ...
By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the ...
Johnson & Johnson (NYSE:JNJ) today announced results from the final analysis of the Phase 3 PROTEUS study showing the investigational use of apalutamide plus hormone therapy (androgen deprivation ...
Researchers at the University of Cincinnati College of Medicine have found that patients who continue to smoke ahead of lung ...
Daily Mail on MSN
Postman takes legal action against hospital after having surgery to remove cancer he did not have
Mark Welland, 61, was told by oncologists that he had a cancerous lump on his pancreas so had keyhole surgery at the Royal ...
Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction in the ris ...
New research shows a novel pill is helping people with advanced pancreatic cancer live longer. It's not a cure, as the drug's ...
Researchers at the University of Cincinnati College of Medicine have found that patients who continue to smoke ahead of lung cancer surgery have a higher risk of pulmonary complications, but their ...
For many breast cancer patients, surgery ends one ordeal and begins another. The tumor may be gone, after a mastectomy, the ...
Substantial and sustained weight loss has been linked to a reduced risk of cancer and cancer-related death, mainly in women. Two new studies now provide clues to why the risk is reduced—and suggest ...
Former President Joe Biden recently underwent surgery to remove skin cancer lesions and has been left with a large scar on his forehead, his office says. Biden’s representative, Kelly Scully, ...
NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced results from the final analysis of the Phase 3 PROTEUS study, evaluating apalutamide plus hormone therapy (androgen deprivation therapy, ADT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results